logo

For the Inventor, By the Inventor

Harlow, United Kingdom

Andrew Stephen Robert Jennings

This inventor holds 15 USPTO granted patents and 1 published patent application. Top assignees: Chiesi Farmaceutici S.p.a., Argenta Discovery Limited. Active years: 2011-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Stephen Robert Jennings. Retrieved from https://idiyas.com/inventor/andrew-stephen-robert-jennings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 26.7

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 54(Granted Patents)


Company Filing History:

goldMedal14 out of 342 
 
Chiesi Farmaceutici S.p.a.
 patents
silverMedal1 out of 2 
 
Argenta Discovery Limited
 patents

Years Active: 2011-2019

Loading Chart...
15 patents (USPTO):Explore Patents
1. 10172830 - Pyrazolone compounds having human neutrophil elastase inhibitory properties (2019-01-08),
2. 10023558 - Compounds (2018-07-17),
3. 9862706 - Compounds (2018-01-09),
4. 9802919 - Compounds (2017-10-31),
5. 9573949 - Derivatives of [1, 2, 4] triazolo [4, 3-a] pyridine as P38—MAP kinase inhibitors (2017-02-21),
6. 9527846 - Kinase inhibitors (2016-12-27),
7. 9440974 - Kinase inhibitors (2016-09-13),
8. 9315503 - Kinase inhibitors (2016-04-19),
9. 9181242 - Kinase inhibitors (2015-11-10),
10. 9145413 - Kinase inhibitors (2015-09-29),
11. 9139584 - Kinase inhibitors (2015-09-22),
12. 9029373 - Kinase inhibitors (2015-05-12),
13. 8907094 - Kinase inhibitors (2014-12-09),
14. 8835431 - Kinase inhibitors (2014-09-16),
15. 7994211 - Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses (2011-08-09),

Title: Andrew Stephen Robert Jennings: Pioneering Innovations in Pharmaceuticals

Introduction:

Inventor Andrew Stephen Robert Jennings is a trailblazer in the field of pharmaceutical innovation, hailing from Harlow, GB. With an impressive portfolio of 15 patents, his work continues to inspire the next generation of inventors.

Latest Patents:

One of his groundbreaking inventions includes "Pyrazolone compounds having human neutrophil elastase inhibitory properties." These compounds, designed to treat diseases involving human neutrophil elastase, showcase Jennings' commitment to creating solutions with transformative impacts.

Career Highlights:

Jennings has made significant contributions to renowned companies such as Chiesi Farmaceutici S.p.a. and Argenta Discovery Limited. His expertise and passion for innovation have led to the development of life-changing pharmaceutical solutions.

Collaborations:

Throughout his career, Jennings has collaborated with esteemed professionals in the field, including colleagues like Elisabetta Armani and Lilian Alcaraz. Together, they have worked tirelessly to push the boundaries of pharmaceutical research and development.

Conclusion:

Andrew Stephen Robert Jennings stands as a testament to the power of innovation and dedication in shaping the future of pharmaceuticals. His inventive spirit and unwavering pursuit of excellence serve as an inspiration to aspiring inventors worldwide, fueling the drive for impactful solutions that benefit society as a whole.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…